Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Brown, Julie ^a   Farquhar, Cindy ^a   Lee, Olivia ^b   Toomath, Robyn ^c   Jepson, Ruth G ^d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Wellington Hospital ^*

^c WELLINGTON HOSPITAL   (New Zealand)

^d UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

Acne vulgaris *drug therapy ; Aldosterone antagonists *therapeutic use ; Drug therapy, combination; Female; Glucocorticoids *therapeutic use ; Hirsutism *drug therapy ; Humans; Male; Randomized controlled trials as topic; Spironolactone *therapeutic use

Indexed keywords

ANDROSTENEDIONE; CANRENOATE POTASSIUM; CYPROTERONE ACETATE; DEXAMETHASONE; FINASTERIDE; FLUTAMIDE; METFORMIN; PLACEBO; PRASTERONE; SPIRONOLACTONE; STEROID; TESTOSTERONE;

ACNE; ACNE VULGARIS; BLOOD SAMPLING; CLINICAL TRIAL; CUSHING SYNDROME; DIARRHEA; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; HAIR GROWTH; HIRSUTISM; HUMAN; LIBIDO DISORDER; MENORRHAGIA; MENSTRUATION DISORDER; META ANALYSIS; POLYMENORRHEA; POLYURIA; REVIEW; SEBUM; SEBUM SECRETION; SYSTEMATIC REVIEW; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION;

EID: 70349085427     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000194.pub2     Document Type: Review

References (26)

1. Ganie MA, Khurana ML, Eunice M, Gulati M, Dwivedi SN, Ammini AC. Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: An open-labeled study. The Journal of Clinical Endocrinology and Metabolism 2004; 89(6):2756-2762. (Pubitemid 38766362)
2. Lobo R, Shoupe D, Serafini P, Brinton D, Horton R. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertility & Sterility 1985;43(2):200-205 (Pubitemid 15127342)
3. Lumachi F, Rondinone R. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism. Fertility & Sterility 2003;79(4):942-946 (Pubitemid 36385018)
4. McLellan AR, Rentoul J, MacKie R, McInnes GT. Lack of effect of spironolactone on hair shaft diameter in hirsute females. Postgraduate Medical Journal 1989;65:459-462 (Pubitemid 19184278)
5. Moghetti P, Tosti F, Tosti A, Negri C, Misciali C, Perrone F, et al.Comparison of spironolactone, flutamide and finasteride efficacy in the treatment of hirsutism: a randomised, double blind, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 2000;85(1):89-94. (Pubitemid 32268796)
6. Muhlemann MF, Carter GD, Cream JJ, Wise P. Oral spironolactone: an effective treatment for acne vulgaris in women. British Journal of Dermatology 1986;115(2):227-232 (Pubitemid 16069468)
7. Prezelj J, Kocijancic A, Andolsek L. Dexamethasone and spironolactone in the treatment of non tumourous hyperandrogenism. Gynaecological Endocrinology 1989;3(4):281-288 (Pubitemid 20038898)
8. Walton S, Cunliffe WJ, Lookingbill P, Keczkes K. Lack of effect of topical spironolactone on sebum excretion. British Journal of Dermatology 1986;114(2):261-269 (Pubitemid 16131435)
9. Wong IL, Morris RS, Chang L, Spahn MA, Stanczyk FZ, Lobo RA. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsutewomen 1995;80 (1):233-238.
10. Castello R, Moghetti A, Magnani C, Zardini G, Furlani L, Tosi F, et al.Spironolactone versus spironolactone plus liquorice in hirsutism: Hormonal evaluation. Journal of Gynaecological Endocrinology 1991; 7-8(1-4):34-77. (Pubitemid 23278141)
11. Gokmen O, Senoz B, Isik A. Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome. Gynecological Endocrinology 1996;10(4):249-255 (Pubitemid 26343485)
12. Gomez B, Ramelet A, Ruedi B, Muhlemann M. Lack of effect of a spironolactone containing cream on hair growth in hirsute women. Dermatologica 1987;174:102-104 (Pubitemid 17008148)
13. Goodfellow A, Alaghband-Zadeh J, Carter G, Cream J, Holloand S, Scully J, et al.Oral spironolactone improves acne vulgaris and reduces sebum excretion. British Journal of Dermatology 1984;111(2):209-214 (Pubitemid 14052303)
14. Pittaway D, Maxson W, Wentz A. Spironolactone in combination drug therapy for unresponsive hirsutism. Fertility & Sterility 1985; 43(6):878-882 (Pubitemid 15060026)
15. Siegberg R, Ylostalo P, Laatikainen T, Pelkonen R, Stenman U. Endocrine and clinical effects of spironolactone in female hyperandrogenism. Archives of Gynecology 1987;240(2):67-73. (Pubitemid 17162931)
16. Unluhizarci K, Everest H, Bayram F, Kelestimur F. Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism. Fertility & Sterility 2002;78(6):1331-1332 (Pubitemid 35463139)
17. Wild R, Demers L, Bpplebaum-Bowden D, Lenker R. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone. Contraception 1991;44(2):113-124
18. Adams J, Frank S, Polson DW, Mason HD, Abdulwahid N, Tucker M et. al. Multifollicular ovaries:clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985; 2(8469-70):1375-1379 (Pubitemid 16138549)
19. Burke B, Cunliffe W. The assessment of acne vulgaris - the Leeds technique. British Journal of Dermatology 1984;111(1):83-92. (Pubitemid 14086231)
20. Eden J. The polycystic ovary syndrome. Australian & New Zealand Journal of Obstetrics and Gynaecology 1989;29(4):403-416
21. Fox R. Polycystic ovary disease. Current Opinion Obstetrics & Gynecology 1990;2(2):370-377
22. McMullen GR, Van Herle AJ. Hirsutism and the effectiveness of spironolactone in its management. Journal of Endocrinological Investigation 1993;16(11):925-932
23. Rabe T, Grunwald K, Runneaum B. Management of androgenisation. Management of androgenisation. Berlin: Diesbach Verlag, 1993: 8-20.
24. Rittmaster RS.Medical treatment of androgen dependent hirsutism. Journal of Clinical Endocrinology and Metabolism 1995;80(9):2559-2563
25. Sciarra F, Toscano V, Concolino G, Di Silverio F. Antiandrogens: clinical applications. Journal of Steroid Biochemistry & Molecular Biology 1990;37(3):349-362
26. Van der Spuy ZM, le Roux PA. Cyproterone acetate for hirsutism. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD001125]